Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Catheter Precision, Inc. Common Stock (NY: VTAK )

0.3560 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EST, Feb 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Catheter Precision, Inc. Common Stock

< Previous 1 2 3 4 Next >
Catheter Precision to Attend and Participate in the 13th Internation Symposium on Left Atrial Appendage
From Catheter Precision, Inc.
Via GlobeNewswire
Catheter Precision, Inc.  Announces The Closing of its Acquisition of PeriKard, LLC
From Catheter Precision, Inc.
Via GlobeNewswire
Catheter Precision to Attend the 30th International Atrial Fibrillation Symposium
Via ACCESSWIRE
Catheter Precision, Inc. Announces Definitive Agreement to Acquire PeriKard, LLC
Via ACCESSWIRE
Catheter Precision, Inc. Announces Initial LockeT Purchase From the University of Tennessee Medical Center
Via ACCESSWIRE
Catheter Precision, Inc. Announces New Chief Financial Officer
Via ACCESSWIRE
Catheter Precision, Inc. Announces Initial LockeT Purchase From Montefiore Medical Center
Via ACCESSWIRE
Catheter Precision, Inc. Announces Third Quarter Update and Financial Results
Via ACCESSWIRE
Catheter Precision, Inc. Announces New Clinical Data Presented at SCRN
Via ACCESSWIRE
Catheter Precision, Inc. Announces Exercise of Warrants for $4.9 Million of Gross Proceeds
Via ACCESSWIRE
Catheter Precision to Attend Society for Cardiac Robotic Navigation With New Clinical Data Presented on October 28 – 29
Via ACCESSWIRE
Catheter Precision Announces Clinical Publication of Non-Invasive Stereotactic Radioablation Using VIVO
Via ACCESSWIRE
Catheter Precision to Attend the International Symposium on Catheter Ablation Techniques
Via ACCESSWIRE
Catheter Precision Scheduled to Attend the International Ventricular Tachycardia (VT) Symposium October 11 - 12 in New York City
Via ACCESSWIRE
Catheter Precision Continues to Expand Clinical Data and Acceptance of VIVO
Via ACCESSWIRE
Catheter Precision, Inc. Receives Chinese Patent for LockeT
Via ACCESSWIRE
Catheter Precision, Inc. Expands LockeT Distribution to Middle East
Via ACCESSWIRE
Catheter Precision, Inc. (NYSE American: VTAK) Reports First Purchase Order for LockeT in the Pacific Northwest Territory
Via ACCESSWIRE
Presentation at European Society of Cardiology Demonstrates VIVO Accuracy in Complex VT Patients
Via ACCESSWIRE
Catheter Precision, Inc. (NYSE American:VTAK) Reports First Purchase Order for LockeT in a New US Territory
Via ACCESSWIRE
Catheter Precision, Inc. Announces Closing of $3.6 Million Underwritten Public Offering and Exercise of Overallotment Option
Via ACCESSWIRE
Catheter Precision, Inc. Announces Pricing of $3.1 Million Underwritten Public Offering
Via ACCESSWIRE
Catheter Precision, Inc. (NYSE American: VTAK) Reports Q2 2024 Highlights and Operational Performance Report
Via ACCESSWIRE
Catheter Precision, Inc. Announces Publication of LockeT Data in the Journal of Cardiovascular Electrophysiology
Via ACCESSWIRE
LargeCap Big Tech Stocks Report Earnings Today: Discover SmallCap Stocks Inside to Watch Now!
Via AB Newswire
Catheter Precision, Inc. Completes Enrollment of 75 Patients in LockeT-II Study
Via ACCESSWIRE
5 Stocks in the News to Watch Now: LGVN, PRSO, SIRI, INBS, VTAK
Via AB Newswire
Exposures Product Safety
Catheter Precision Inc. (NYSE American: VTAK) Moves Forward with Aggressive Expansion Strategy and New Share Structure
Via AB Newswire
Catheter Precision, Inc. Announces the Completion of Patient Follow-up for the VIVO European Registry and New Product Evaluations of VIVO
Via ACCESSWIRE
Catheter Precision, Inc. Announces Effectiveness of 1-for-10 Reverse Stock Split
Via ACCESSWIRE
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.